Financial Daily from THE HINDU group of publications
Saturday, Aug 20, 2005
Financial Daily from THE HINDU group of publications Saturday, Aug 20, 2005 |
|
|
|
|
|
Corporate
-
Announcements Marketing - New Products & Services Shantha Biotechnics unveils 4-in-1 vaccine Our Bureau
Hyderabad , Aug. 19 SHANTHA Biotechnics Ltd has launched a four-in-one vaccine for diphtheria, tetanus, pertussis and hepatitis-B for children. Shantetra, the combination vaccine, would reduce the number of pricks from six to three and trips to doctors for the administration of vaccine. The vaccine can be administered to infants from the sixth week. Announcing the launch of the vaccine here on Friday, Mr K.I. Varaprasada Reddy, Managing Director of Shantha Biotechnics, said combination vaccines were gaining currency globally as they offered convenience and reduced effort. The new product would partly cut into the company's standalone hepatitis-B vaccine (Shanvac-B) sales. But the company felt that the hepatitis-B vaccine would still have good potential, as people in other age groups too needed it. On market potential for these vaccines, he said over three crore children born globally each year didn't receive any immunisation.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|